Musa Aydınlı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Musa Aydınlı has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Remzi Ekici
Department of Gastroenterology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Türkiye
2 shared publications - Abdi İbrahim Halil Sönmez
Department of Hematology, Kilis Prof. Dr. Alaeddin Yavaşça State Hospital, Kilis 79090, Türkiye
1 shared publication - Ali Gokhan Akcay
Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkiye
1 shared publication - Alper Sevinc
Division of Medical Oncology, Department of Internal Medicine, Gaziantep Medical Point Private Hospital, TR-27310 Gaziantep, Turkey
1 shared publication - Beyhan Cengiz
Gazi University
1 shared publication - Cemal Nuri Ercin
Sağlık Bilimleri Üniversitesi, Gülhane Tıp Fakültesi, Gastroenteroloji Bilim Dalı, Ankara
1 shared publication
Latest Publications
- 1 January 2026
- Published by Kare Publishing in Hepatology Forum
- Vol. 7 (2) , 167-170
Peritonitis due to brucellosis in a patient newly diagnosed with liver cirrhosis complicated by ascites: A case report and literature review
Brucellosis is a common zoonotic disease with a wide variety of clinical manifestations. Spontaneous bacterial peritonitis (SBP) is a rare form among them. Here, we present the case of a 63-year-old woman with newly diagnosed liver cirrhosis complicated with ascites and diagnosed as spontaneous bacterial peritonitis with Brucella spp. growth in culture, and the literature is reviewed.
- 1 January 2026
- Published by Kare Publishing in Hepatology Forum
- Vol. 7 (2) , 167-170
Peritonitis due to brucellosis in a patient newly diagnosed with liver cirrhosis complicated by ascites: A case report and literature review
Brucellosis is a common zoonotic disease with a wide variety of clinical manifestations. Spontaneous bacterial peritonitis (SBP) is a rare form among them. Here, we present the case of a 63-year-old woman with newly diagnosed liver cirrhosis complicated with ascites and diagnosed as spontaneous bacterial peritonitis with Brucella spp. growth in culture, and the literature is reviewed.
- 19 December 2025
- Published by Kare Publishing in Journal of Enterocolitis
Solitary Rectal Ulcer Diagnosed in a Malignancy-Mimicking Polypoid Rectal Lesion: A Case Report
Solitary rectal ulcer syndrome (SRUS) is a chronic anorectal disorder of unknown etiology, most commonly observed in young adults. The diagnosis is established through a combination of clinical, endoscopic, and histopathological findings. Its polypoid appearance, which may mimic malignancy, often leads to misdiagnosis. Herein, we present the case of a 64-year-old woman with a history of constipation and digital evacuation, who was found to have a polypoid rectal lesion resembling malignancy, which was subsequently diagnosed as SRUS.
- 19 December 2025
- Published by Kare Publishing in Journal of Enterocolitis
Solitary Rectal Ulcer Diagnosed in a Malignancy-Mimicking Polypoid Rectal Lesion: A Case Report
Solitary rectal ulcer syndrome (SRUS) is a chronic anorectal disorder of unknown etiology, most commonly observed in young adults. The diagnosis is established through a combination of clinical, endoscopic, and histopathological findings. Its polypoid appearance, which may mimic malignancy, often leads to misdiagnosis. Herein, we present the case of a 64-year-old woman with a history of constipation and digital evacuation, who was found to have a polypoid rectal lesion resembling malignancy, which was subsequently diagnosed as SRUS.
- Open Access
- 28 February 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (1) , 21-30
Evaluation of Her2 Positivity in Gastric Cancer Using Two Different Methods: A Prospective Study
BACKGROUND: Stomach cancer is one of the most common gastrointestinal tract tumors. Its incidence varies according to ethnic group, geographical conditions, dietary habits, economic status, lifestyle and Helicobacter pylori prevalence. Genetic factors play a major role in the pathogenesis of gastric cancer, and the human epidermal growth factor receptor 2 Her2/neu (c-erb B2) gene is one of these factors. METHOD: The objective of this study is to compare any correlation between the amplification level of Her2/neu gene in gastric cancer by real-time polymerase chain reaction (RT-PCR) with Her2 protein overexpression obtained from the same tissue and studied with immunohistochemisry (IHC), and in the event of positivity, to determine its relationshipwith other known prognostic factors such as age, gender, stage, tumor localization and histological type. RESULTS: IHC results indicated Her2 overexpression in 5 (10%) patients and RT-PCRindicated amplification also in 5 (10%) patients. There was no significant correlation between the results determined by the two methods (p> 0.05). Additionally, no statistically significant difference was detected between prognostic factors and gene expressions in tumor tissues (p> 0.05). CONCLUSION: Her2 gene amplification and protein overexpression can potentially contribute to tumor development. Further studies are needed to evaluate false negativity, investigate patient survival in terms of its contribution to prognosis, and corroborate our hypothesis.
- 28 February 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (1) , 21-30
Open AccessEvaluation of Her2 Positivity in Gastric Cancer Using Two Different Methods: A Prospective Study
BACKGROUND: Stomach cancer is one of the most common gastrointestinal tract tumors. Its incidence varies according to ethnic group, geographical conditions, dietary habits, economic status, lifestyle and Helicobacter pylori prevalence. Genetic factors play a major role in the pathogenesis of gastric cancer, and the human epidermal growth factor receptor 2 Her2/neu (c-erb B2) gene is one of these factors. METHOD: The objective of this study is to compare any correlation between the amplification level of Her2/neu gene in gastric cancer by real-time polymerase chain reaction (RT-PCR) with Her2 protein overexpression obtained from the same tissue and studied with immunohistochemisry (IHC), and in the event of positivity, to determine its relationshipwith other known prognostic factors such as age, gender, stage, tumor localization and histological type. RESULTS: IHC results indicated Her2 overexpression in 5 (10%) patients and RT-PCRindicated amplification also in 5 (10%) patients. There was no significant correlation between the results determined by the two methods (p> 0.05). Additionally, no statistically significant difference was detected between prognostic factors and gene expressions in tumor tissues (p> 0.05). CONCLUSION: Her2 gene amplification and protein overexpression can potentially contribute to tumor development. Further studies are needed to evaluate false negativity, investigate patient survival in terms of its contribution to prognosis, and corroborate our hypothesis.